Quel est l’objectif du BCU et quelle place pour l’oncogenétique dans ce congrès?
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
Breast imaging technology has significantly advanced over the years. While we once relied on 2D mammography, we now have more precise options like 3D imaging. This advancement allows us to identify lesions more effectively than with 2D mammograms.
One key advantage of 3D imaging is the ability to detect smaller lesions at an earlier stage. It provides clearer images, enabling better assessment and earlier treatment.Additionally, 3D imaging offers insights into the quality and abnormality of a lesion that 2D mammography cannot provide.
It’s essential to note that mammography isn’t the only imaging technology available for breast cancer detection. Contrast-enhanced mammography, MRI, and ultrasound are other options. Ultrasound imaging has evolved with automated breast ultrasound systems, offering additional benefits in breast cancer detection.
These advancements have significantly improved our ability to detect and treat breast cancer, providing greater sensitivity and specificity.
It’s important to remember that no single imaging modality can identify all breast abnormalities. A multidisciplinary approach, combining various imaging technologies and clinical expertise, is crucial for effective breast cancer detection and treatment.
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
Fredérique PENAULT LORCA
Dalila AHNOU
Copyright © 2025 - BCU
Our website uses cookies to provide you the best experience. However, by continuing to use our website, you agree to our use of cookies. For more information, read our Cookie Policy.